Document Detail


Primary triple valve surgery for advanced rheumatic heart disease in Mainland China: a single-center experience with 871 clinical cases.
MedLine Citation:
PMID:  17336080     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Triple valve surgery (TVS) is still of choice for advanced rheumatic heart disease (RHD), which has been associated with reported poor early and late outcomes. We describe the short- and long-term results after TVS in last two decades in Mainland China. METHODS: From January 1985 to January 2005, a total of 871 patients (217 men, 654 women), with mean age of 42+/-11 years, underwent primary TVS for isolated advanced RHD. All patients received replacement procedures in mitral and aortic position (845 mechanical, 26 bioprosthetic), and 840 patients received repair procedures and the other 31 received replacement procedures in tricuspid position (9 mechanical, 22 bioprosthetic). Preoperative, perioperative, and postoperative data were retrospectively analyzed and risk factors affecting early and late survival were evaluated. RESULTS: The 30-day hospital mortality was 8% (n=71). Presence of ascites, New York Heart Association (NYHA) class IV and lower left ventricular ejection fraction (LVEF) were identified as independent risk factors for hospital mortality. Overall long-term survival rate was 71%+/-3% at 5 years, and 59%+/-5% at 10 years. The cardiac survival rate was 75%+/-3% at 5 years and 63%+/-4% at 10 years. The event-free survival rate at 5 years and 10 years was 61%+/-6% and 41%+/-13%, respectively. Multivariate analysis revealed advanced age, NYHA class IV and lower LVEF were associated with increased late mortality. The freedom from thromboembolism and anticoagulation-related hemorrhage at 10 years was 90%+/-4% and 81%+/-5%, respectively. Of the 508 patients still alive, 376 (74%) were in NYHA class I and II. CONCLUSIONS: Primary TVS for advanced RHD appears to offer satisfactory short- and long-term results with excellent symptomatic improvement. Cardiac-related late mortality following TVS may be improved by early surgical treatment before NYHA class IV or deterioration of LVEF occurs.
Authors:
Qing-Qi Han; Zhi-Yun Xu; Bao-Ren Zhang; Liang-Jian Zou; Jia-Hua Hao; Sheng-Dong Huang
Publication Detail:
Type:  Journal Article     Date:  2007-03-01
Journal Detail:
Title:  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery     Volume:  31     ISSN:  1010-7940     ISO Abbreviation:  Eur J Cardiothorac Surg     Publication Date:  2007 May 
Date Detail:
Created Date:  2007-04-09     Completed Date:  2007-07-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804069     Medline TA:  Eur J Cardiothorac Surg     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  845-50     Citation Subset:  IM    
Affiliation:
Department of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aortic Valve / surgery
Bioprosthesis
Cardiac Surgical Procedures / methods
Cause of Death
China / epidemiology
Female
Heart Valve Prosthesis Implantation / methods
Heart Valves / surgery*
Humans
Male
Middle Aged
Mitral Valve / surgery
Postoperative Complications
Reoperation
Retrospective Studies
Rheumatic Heart Disease / mortality,  physiopathology,  surgery*
Survival Analysis
Treatment Outcome
Tricuspid Valve / surgery
Ventricular Dysfunction, Left / mortality

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polysialylation of NCAM is upregulated by hyperthermia and participates in heat shock preconditionin...
Next Document:  Brain oxygen and metabolism is dependent on the rate of low-flow cardiopulmonary bypass following ci...